Skip to Content



Biogen CEO on Controversial Alzheimer's Drug: "There Is Hope"

December 05, 2019 00:00 AM UTC
- Updated September 02, 2020 11:34 AM UTC

CEO Michel Vounatsos says if the drug is approved it will require new payment innovations to make it affordable for the people who need it.